Two States Require Industry To Pay For Ongoing Drug Take-Back Programs
Executive Summary
Consumer Healthcare Products Association looks to stem expansion of state-mandated drug take-back programs with programs that use existing facilities and infrastucture and don't require industry funidng, says state affairs VP Carlos Gutierrez. State bills limiting sales of DXM to minors and expansion of the NPLEx system to track PSE sales also are on CHPA’s radar.
You may also be interested in...
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
Pennsylvania is 17th US state to limit sales of dextromethorphan OTCs to consumers 18 and older because teenagers' abuse of the ingredient for intoxicating effect remains a common problem.
States With Age Restriction On OTC DXM Sales Number 17 – And Counting
Pennsylvania is 17th US state to limit sales of dextromethorphan OTCs to consumers 18 and older because teenagers' abuse of the ingredient for intoxicating effect remains a common problem.
CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates
OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.